{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T07:23:31Z","timestamp":1773213811541,"version":"3.50.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,5,31]],"date-time":"2020-05-31T00:00:00Z","timestamp":1590883200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,31]],"date-time":"2020-05-31T00:00:00Z","timestamp":1590883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>This study investigates the association between the treatment with heparin and mortality in patients admitted with Covid-19. Routinely recorded, clinical data, up to the 24th of April 2020, from the 2075 patients with Covid-19, admitted in 17 hospitals in Spain between the 1st of March and the 20th of April 2020 were used. The following variables were extracted for this study: age, gender, temperature, and saturation of oxygen on admission, treatment with heparin, hydroxychloroquine, azithromycin, steroids, tocilizumab, a combination of lopinavir with ritonavir, and oseltamivir, together with data on mortality. Multivariable logistic regression models were used to investigate the associations. At the time of collecting the data, 301 patients had died, 1447 had been discharged home from the hospitals, 201 were still admitted, and 126 had been transferred to hospitals not included in the study. Median follow up time was 8 (IQR 5\u201312) days. Heparin had been used in 1734 patients. Heparin was associated with lower mortality when the model was adjusted for age and gender, with OR (95% CI) 0.55 (0.37\u20130.82) p\u2009=\u20090.003. This association remained significant when saturation of oxygen\u2009&lt;\u200990%, and temperature\u2009&gt;\u200937 \u00b0C were added to de model with OR 0.54 (0.36\u20130.82) p\u2009=\u20090.003, and also when all the other drugs were included as covariates OR 0.42 (0.26\u20130.66) p\u2009&lt;\u20090.001. The association between heparin and lower mortality observed in this study can be acknowledged by clinicians in hospitals and in the community. Randomized controlled trials to assess the causal effects of heparin in different therapeutic regimes are required.<\/jats:p>","DOI":"10.1007\/s11239-020-02162-z","type":"journal-article","created":{"date-parts":[[2020,5,31]],"date-time":"2020-05-31T05:02:35Z","timestamp":1590901355000},"page":"298-301","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":132,"title":["The association between treatment with heparin and survival in patients with Covid-19"],"prefix":"10.1007","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7177-0262","authenticated-orcid":false,"given":"Luis","family":"Ayerbe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Risco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0449-869X","authenticated-orcid":false,"given":"Salma","family":"Ayis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,31]]},"reference":[{"key":"2162_CR1","unstructured":"WHO (2020) Coronavirus disease (COVID-19) Pandemic. https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019. Accessed 28 April 2020"},{"key":"2162_CR2","unstructured":"WHO (2020) Naming the coronavirus disease (COVID-19) and the virus that causes it. https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/technical-guidance\/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it.  Accessed 28 April 2020"},{"key":"2162_CR3","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/s41591-020-0822-7","volume":"26","author":"JT Wu","year":"2020","unstructured":"Wu JT, Leung K, Bushman M et al (2020) Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China. Nat Med 26:506\u2013510","journal-title":"Nat Med"},{"issue":"10229","key":"2162_CR4","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/S0140-6736(20)30686-3","volume":"395","author":"The Lancet","year":"2020","unstructured":"The Lancet (2020) COVID-19: learning from experience. Lancet 395(10229):1011","journal-title":"Lancet"},{"key":"2162_CR5","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1056\/NEJMc2007575","volume":"382","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Xia M, Zhang S et al (2020) Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med 382:e38","journal-title":"N Engl J Med"},{"key":"2162_CR6","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1712097","author":"M Cattaneo","year":"2020","unstructured":"Cattaneo M, Bertinato E, Birocchiet S et al (2020) Pulmonary embolism or pulmonary thrombosis in COVID-19? Is the recommendation to use high-dose heparin for thromboprophylaxis justified? Thromb Haemost. https:\/\/doi.org\/10.1055\/s-0040-1712097","journal-title":"Thromb Haemost"},{"issue":"4","key":"2162_CR7","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/jth.14768","volume":"18","author":"N Tang","year":"2020","unstructured":"Tang N, Li D, Wang X, Sun Z (2020) Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 18(4):844\u2013847","journal-title":"J Thromb Haemost"},{"issue":"20","key":"2162_CR8","doi-asserted-by":"publisher","first-page":"30367","DOI":"10.1016\/S1473-3099(20)30367-4","volume":"S1473-3099","author":"M Lang","year":"2020","unstructured":"Lang M, Som A, Mendoza D et al (2020) Hypoxaemia related to COVID-19: vascular and perfusion abnormalities on dual-energy CT. Lancet Infect Dis S1473-3099(20):30367\u201330364. https:\/\/doi.org\/10.1016\/S1473-3099(20)30367-4","journal-title":"Lancet Infect Dis"},{"key":"2162_CR9","doi-asserted-by":"publisher","DOI":"10.1101\/2020.04.19.20054262","author":"L Carsana","year":"2020","unstructured":"Carsana L, Sonzogni A, Nasr A et al (2020) Pulmonary post-mortem findings in a large series of COVID-19 cases from Northern Italy. MedRxIV. https:\/\/doi.org\/10.1101\/2020.04.19.20054262","journal-title":"MedRxIV"},{"key":"2162_CR10","unstructured":"HM Hospitales (2020) https:\/\/www.hmhospitales.com\/. Accessed 28 April 2020"},{"key":"2162_CR11","unstructured":"Stata 14 (2020) https:\/\/www.stata.com\/stata14\/. Accessed 28 April 2020"},{"issue":"5","key":"2162_CR12","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1111\/jth.14817","volume":"18","author":"N Tang","year":"2020","unstructured":"Tang N, Bai H, Chen X et al (2020) Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost 18(5):1094\u20131099","journal-title":"J Thromb Haemost"},{"key":"2162_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.05.001","author":"I Paranjpe","year":"2020","unstructured":"Paranjpe I, Fuster V, Lala A et al (2020) Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19. J Am Coll Cardiol. https:\/\/doi.org\/10.1016\/j.jacc.2020.05.001","journal-title":"J Am Coll Cardiol"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-020-02162-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-020-02162-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-020-02162-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,30]],"date-time":"2021-05-30T19:21:45Z","timestamp":1622402505000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-020-02162-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,31]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["2162"],"URL":"https:\/\/doi.org\/10.1007\/s11239-020-02162-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.05.27.20114694","asserted-by":"object"}]},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,31]]},"assertion":[{"value":"31 May 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The Ethics committee of HM Hospitales approved this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All data were anonymized before researchers could access it.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Authors have agreed for the final version of this paper to be submitted for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}